SCHEMBL24601547

SCHEMBL24601547

Cc1c(-c2ccccc2)c(C)c(-c2ccccc2)c(-c2ccc3c(c2)c2c4c5ccccc5n5c6ccc(-c7c(-c8ccccc8)c(C)c(-c8ccccc8)c(C)c7-c7ccccc7)cc6c(c6c7ccccc7n3c62)c45)c1-c1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSPO P30536 1/20 0.34
KDM4E B2RXH2 6/20 0.33
MAPT P10636 4/20 0.33
NPY5R Q15761 1/20 0.33
KMT2A Q03164 4/20 0.33
LMNA P02545 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MEN1 O00255 3/20 0.32
GAA P10253 2/20 0.32
RCE1 Q9Y256 1/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
HPGD P15428 2/20 0.31
HSD17B10 Q99714 1/20 0.31
CHEK1 O14757 2/20 0.31
WEE1 P30291 2/20 0.31
BRD4 O60885 1/20 0.31
ALDH1A1 P00352 3/20 0.31
TOP2A P11388 1/20 0.30
PCSK9 Q8NBP7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601546 0.94 KDM4E (0.33) KDM4EMAPTKMT2ALMNASMN1; SMN2
SCHEMBL24601658 0.91 TSPO (0.36) TSPOKDM4EMAPTNPY5RKMT2A
SCHEMBL24601656 0.85 KDM4E (0.35) KDM4EMAPTKMT2ALMNASMN1; SMN2
SCHEMBL22178510 0.83 TSPO (0.43) TSPOHPGDHSD17B10
SCHEMBL22178499 0.83 TSPO (0.43) TSPOHPGDHSD17B10
SCHEMBL24601657 0.82 KMT2A (0.33) TSPOKDM4EKMT2ALMNASMN1; SMN2
SCHEMBL22178509 0.80 TSPO (0.41) TSPOKMT2AMEN1ESR1
SCHEMBL24601509 0.80 HSD17B10 (0.34) TSPOKDM4EMAPTKMT2ALMNA
SCHEMBL24601430 0.79 HSD17B10 (0.36) TSPOKDM4EMAPTKMT2AMEN1
SCHEMBL24601649 0.79 HSD17B10 (0.36) TSPOKDM4EMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 TSPO 3404/4885KDM4E 3163/4885MAPT 1370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.